Grown Rogue International (GRUSF) Restructuring Costs (2019 - 2020)
Grown Rogue International (GRUSF) recorded quarterly Restructuring Costs of $8852.0 in Q3 2020, up 103.28% quarter-over-quarter from -$269934.0 in Q4 2019.
Grown Rogue International (GRUSF) Restructuring Costs (2019 - 2020) Analysis & Trends
Grown Rogue International's Restructuring Costs history runs 2 years deep, the most recent figure standing at $8852.0 for Q3 2020.
- In Q3 2020, Restructuring Costs changed N/A year-over-year to $8852.0; the TTM figure through Jul 2020 stood at -$261082.0 (changed N/A YoY), while the FY2019 annual figure was $3.5 million, changed N/A from the prior year.
- Restructuring Costs was $8852.0 for Q3 2020 at Grown Rogue International, up from -$269934.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $3.7 million in Q1 2019 to a low of -$269934.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2020 | 8,852.00 |
| Oct 31, 2019 | -269,934.00 |
| Jan 31, 2019 | 3.72 Mn |